Neurelis Submits Particle Sciences’ Nasal Delivery Formulation to NDA
A proprietary nasal delivery formulation of diazepam for the treatment of epilepsy developed by contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has been submitted as…
Share